Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.9 CAD 2.11% Market Closed
Market Cap: 1.1B CAD
Have any thoughts about
Cronos Group Inc?
Write Note

Cronos Group Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cronos Group Inc
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Cronos Group Inc
TSX:CRON
Total Receivables
$33.5m
CAGR 3-Years
21%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Total Receivables
$2.1B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
1%
Sundial Growers Inc
NASDAQ:SNDL
Total Receivables
CA$27.1m
CAGR 3-Years
19%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Total Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Total Receivables
CA$103m
CAGR 3-Years
3%
CAGR 5-Years
51%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Total Receivables
$43.8m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Cronos Group Inc
Glance View

Market Cap
1.1B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.01 CAD
Overvaluation 65%
Intrinsic Value
Price

See Also

What is Cronos Group Inc's Total Receivables?
Total Receivables
33.5m USD

Based on the financial report for Jun 30, 2024, Cronos Group Inc's Total Receivables amounts to 33.5m USD.

What is Cronos Group Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
11%

Over the last year, the Total Receivables growth was 5%. The average annual Total Receivables growth rates for Cronos Group Inc have been 21% over the past three years , 11% over the past five years .

Back to Top